Migraine Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024 – iCrowdNewswire
 
x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Feb 14, 2018 6:38 PM ET

Migraine Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

iCrowdNewswire - Feb 14, 2018

Global Migraine Drugs Market: Overview

About 12–14% of people around the world suffer from a Migraine; it is a type of a headache. According to regional and international rules, migraine is classified by the nature of the attack and its frequency into a chronic migraine and episodic migraine. Prophylactic and abortive are 2 treatments available for the relief of this headache type. Prophylactic treatment is offered to patients suffering from a chronic migraine in order to avoid migraine attacks utilizing medications like topiramate, botulinum toxin, and others. Abortive treatment is offered to terminate severe migraine attack and includes medication like ergot alkaloids, triptans, and others.

Request Free Sample Report @  https://www.zionmarketresearch.com/sample/migraine-drugs-market

Global Migraine Drugs Market: Growth Factors

The increasing awareness regarding a migraine and various options available for its treatment are the major factors boosting the growth of the global migraine drugs market. A number of organizations including the American Headache and Migraine Association are taking efforts to spread awareness about a migraine and hence coming up with programs and providing support to patients so as to spread awareness regarding the disease and further disorders related to a headache. Due to the increasing number of migraine incidences and rising number of unmet needs in the global migraine drugs market, a number of companies are planning to invest in the migraine drugs R&D. This, in turn, is anticipated to propel the global migraine drugs market growth in the near future.

Global Migraine Drugs Market: Segmentation

The global migraine drugs market is segmented on the basis of treatment type, route of administration, and distribution channel. On the basis of treatment type, the global migraine drugs market is segmented as prophylactic and abortive. The prophylactic treatment segment is further sub-segmented as topiramate, botulinum toxin, and others. The abortive treatment segment is further sub-segmented as ergot alkaloids, triptans, and others. On the basis of route of administration, the global market is classified as injectable, oral, and others. The others segment is further sub-segmented as transdermal patches and nasal sprays. On the basis of distribution channel, the global migraine drugs market is diversified as hospital pharmacies, retail pharmacies, and others.

Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/migraine-drugs-market

Global Migraine Drugs Market: Regional Analysis

Asia Pacific is anticipated to dominate the global migraine drugs market and is further expected to continue this trend in the near future. This high growth is mainly owing to the increasing number of people having from a migraine and rising public awareness of the disease in this region. In addition, China and India are the major developing countries contributing to the global migraine drugs market growth in the Asia Pacific region; this is mainly due to the high occurrence of a migraine in these countries. Rising focus on niche products and their launches along with high penetration of novel drug manufacturers will further have a positive impact on the growth of the global migraine drugs market in the near future.

Browse detail report @ https://www.zionmarketresearch.com/report/migraine-drugs-market

Global Migraine Drugs Market: Competitive Players

Some of the major players in the global migraine drugs market include Endo, Allergan, Impax Laboratories, Glaxo Smith Kline, Astellas, Amgen, Bayer, AstraZeneca, Dr. Reddy’s Laboratories, Zogenix, CoLucid, Eli Lilly, Eisai, IntelGenx, Ethypharm, and Klara. Other key players dominating the global market are Johnson & Johnson, Luitpold Pharmaceuticals, Kowa Pharmaceuticals America, Merck, Meda, Pfizer, OptiNose, Raptor, Pozen, SUDA, Redhill, TG Therapeutics, Teva, Winston Pharmaceuticals, and Valeant.

For Media Inquiry contact our sales Team @ [email protected]

About Us: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

 

Contact Information:

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Email: [email protected]

Website: http://www.zionmarketresearch.com

Visit Our Blog: https://zionmarketresearch.wordpress.com

View Related News >